The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.
Murry, C. E., Jennings, R. B., & Reimer, K. A. (1986) · Circulation · doi:10.1161/01.cir.74.5.1124 · Cited by 7,812
Yellon, D. M., & Hausenloy, D. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071667 · Cited by 3,797
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
Levine, B., Kalman, J., Mayer, L., Fillit, H. M., & Packer, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007263230405 · Cited by 2,582 · cited 1×
“Thus, the discovery in the 1990s that TNFα is expressed in all nucleated cell types of the myocardium (including cardiomyocyte itself) has revived the interest in TNFα and its role in cardiac pathophysiological conditions such as myocardial infarction [27,28] and heart failure [29].”
BackgroundProtection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234
Zhao, Z.-Q., Corvera, J. S., Halkos, M. E., Kerendi, F., Wang, N.-P., Guyton, R. A., & Vinten-Johansen, J. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01064.2002 · Cited by 2,070
Effect of Cyclosporine on Reperfusion Injury in Acute Myocardial Infarction
Piot, C., Croisille, P., Staat, P., Thibault, H., Rioufol, G., Mewton, N., Elbelghiti, R., Cung, T. T., Bonnefoy, E., Angoulvant, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071142 · Cited by 1,339
Preconditioning the myocardium: from cellular physiology to clinical cardiology
YELLON, D. M., & DOWNEY, J. M. (2003) · Physiological Reviews · doi:10.1152/physrev.00009.2003 · Cited by 1,062
Deswal, A., Petersen, N. J., Feldman, A. M., Young, J. B., White, B. G., & Mann, D. L. (2001) · Circulation · doi:10.1161/01.cir.103.16.2055 · Cited by 1,012
Hausenloy, D. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.09.024 · Cited by 996
Inflammatory Mediators and the Failing Heart: Past, Present, and the Foreseeable Future
Mann, D. L. (2002) · Circulation Research · doi:10.1161/01.res.0000043825.01705.1b · Cited by 988
A Cathepsin D-Cleaved 16 kDa Form of Prolactin Mediates Postpartum Cardiomyopathy
Hilfiker-Kleiner, D., Kaminski, K., Podewski, E., Bonda, T., Schaefer, A., Sliwa, K., Forster, O., Quint, A., Landmesser, U., Doerries, C., et al. (2007) · Cell · doi:10.1016/j.cell.2006.12.036 · Cited by 906
Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure
Rauchhaus, M., Doehner, W., Francis, D. P., Davos, C., Kemp, M., Liebenthal, C., Niebauer, J., Hooper, J., Volk, H.-D., Coats, A. J. S., et al. (2000) · Circulation · doi:10.1161/01.cir.102.25.3060 · Cited by 810
Imada, K., & Leonard, W. J. (2000) · Molecular Immunology · doi:10.1016/s0161-5890(00)00018-3 · Cited by 610 · cited 1×
“JAKs are a family of tyrosine kinases that are associated with membranes receptors and play a major role in the transduction of signals from the cytosol to the nucleus (see reviews [60,61]).”
BackgroundHausenloy, D. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00455-8 · Cited by 586
Jonassen, A. K., Sack, M. N., Mjøs, O. D., & Yellon, D. M. (2001) · Circulation Research · doi:10.1161/hh2401.101385 · Cited by 523
Ischemic preconditioning protects by activating prosurvival kinases at reperfusion
Hausenloy, D. J., Tsang, A., Mocanu, M. M., & Yellon, D. M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00374.2004 · Cited by 512
Reperfusion injury and its pharmacologic modification.
Opie, L. H. (1989) · Circulation · doi:10.1161/01.cir.80.4.1049 · Cited by 504
Hausenloy, D. J., Tsang, A., & Yellon, D. M. (2005) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2005.03.001 · Cited by 449
Cardioprotection: Nitric Oxide, Protein Kinases, and Mitochondria
Heusch, G., Boengler, K., & Schulz, R. (2008) · Circulation · doi:10.1161/circulationaha.108.805242 · Cited by 441
Kurrelmeyer, K. M., Michael, L. H., Baumgarten, G., Taffet, G. E., Peschon, J. J., Sivasubramanian, N., Entman, M. L., & Mann, D. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070036297 · Cited by 440
Long-Term Benefit of Postconditioning
Thibault, H., Piot, C., Staat, P., Bontemps, L., Sportouch, C., Rioufol, G., Cung, T. T., Bonnefoy, E., Angoulvant, D., Aupetit, J.-F., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.729780 · Cited by 430
Cytokine mRNA expression in postischemic/reperfused myocardium.
Herskowitz, A., Choi, S. J., Ansari, A. A., & Wesselingh, S. L. (1995) · Europe PMC (PubMed Central) · Cited by 374
Ischemic Preconditioning Activates Phosphatidylinositol-3-Kinase Upstream of Protein Kinase C
Tong, H., Chen, W., Steenbergen, C., & Murphy, E. (2000) · Circulation Research · doi:10.1161/01.res.87.4.309 · Cited by 365
The myocardial JAK/STAT pathway: From protection to failure
BOENGLER, K., HILFIKERKLEINER, D., DREXLER, H., HEUSCH, G., & SCHULZ, R. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.08.002 · Cited by 362
Expression and Functional Significance of Tumor Necrosis Factor Receptors in Human Myocardium
Torre-Amione, G., Kapadia, S., Lee, J., Bies, R. D., Lebovitz, R., & Mann, D. L. (1995) · Circulation · doi:10.1161/01.cir.92.6.1487 · Cited by 340
Hausenloy, D. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(03)00043-9 · Cited by 322
Signaling pathways in ischemic preconditioning
Downey, J. M., Davis, A. M., & Cohen, M. V. (2007) · Heart Failure Reviews · doi:10.1007/s10741-007-9025-2 · Cited by 319
Stress-Activated Cytokines and The Heart: From Adaptation to Maladaptation
Mann, D. L. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142249 · Cited by 297
An essential role of the JAK-STAT pathway in ischemic preconditioning
Xuan, Y.-T., Guo, Y., Han, H., Zhu, Y., & Bolli, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161283798 · Cited by 285
Cardioprotection by Ischemic Postconditioning Is Lost in Aged and STAT3-Deficient Mice
Boengler, K., Buechert, A., Heinen, Y., Roeskes, C., Hilfiker-Kleiner, D., Heusch, G., & Schulz, R. (2008) · Circulation Research · doi:10.1161/circresaha.107.164699 · Cited by 280
Kunisada, K., Negoro, S., Tone, E., Funamoto, M., Osugi, T., Yamada, S., Okabe, M., Kishimoto, T., & Yamauchi-Takihara, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.315 · Cited by 273
Pfeffer, L. M., Mullersman, J. E., Pfeffer, S. R., Murti, A., Shi, W., & Yang, C. H. (1997) · Science · doi:10.1126/science.276.5317.1418 · Cited by 258
Ischemic Postconditioning in Pigs: No Causal Role for RISK Activation
Skyschally, A., van Caster, P., Boengler, K., Gres, P., Musiolik, J., Schilawa, D., Schulz, R., & Heusch, G. (2009) · Circulation Research · doi:10.1161/circresaha.108.186429 · Cited by 255
Negoro, S., Kunisada, K., Fujio, Y., Funamoto, M., Darville, M. I., Eizirik, D. L., Osugi, T., Izumi, M., Oshima, Y., Nakaoka, Y., et al. (2001) · Circulation · doi:10.1161/hc3401.095947 · Cited by 252
Activation of gp130 Transduces Hypertrophic Signals via STAT3 in Cardiac Myocytes
Kunisada, K., Tone, E., Fujio, Y., Matsui, H., Yamauchi-Takihara, K., & Kishimoto, T. (1998) · Circulation · doi:10.1161/01.cir.98.4.346 · Cited by 237
Lecour, S., Smith, R. M., Woodward, B., Opie, L. H., Rochette, L., & Sack, M. N. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.1533 · Cited by 235
Self-citationValgimigli, M., Ceconi, C., Malagutti, P., Merli, E., Soukhomovskaia, O., Francolini, G., Cicchitelli, G., Olivares, A., Parrinello, G., Percoco, G., et al. (2005) · Circulation · doi:10.1161/01.cir.0000155614.35441.69 · Cited by 209
Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-α
Maekawa, N., Wada, H., Kanda, T., Niwa, T., Yamada, Y., Saito, K., Fujiwara, H., Sekikawa, K., & Seishima, M. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01738-2 · Cited by 204
Role of STAT3 in Ischemic Preconditioning
Hattori, R., Maulik, N., Otani, H., Zhu, L., Cordis, G., Engelman, R. M., Siddiqui, M. A. Q., & Das, D. K. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1456 · Cited by 200
Zhang, X., Shan, P., Alam, J., Fu, X.-Y., & Lee, P. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408092200 · Cited by 198
Lecour, S., Suleman, N., Deuchar, G. A., Somers, S., Lacerda, L., Huisamen, B., & Opie, L. H. (2005) · Circulation · doi:10.1161/circulationaha.105.581058 · Cited by 189
Self-citationHAUSENLOY, D. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.04.011 · Cited by 188
Tumor Necrosis Factor-α and Mortality in Heart Failure: A Community Study
Dunlay, S. M., Weston, S. A., Redfield, M. M., Killian, J. M., & Roger, V. L. (2008) · Circulation · doi:10.1161/circulationaha.107.759191 · Cited by 186
Gross, E. R., Hsu, A. K., & Gross, G. J. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00003.2006 · Cited by 186
DIRKSEN, M., LAARMAN, G., SIMOONS, M., & DUNCKER, D. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.01.014 · Cited by 185
Sheng, Z., Pennica, D., Wood, W. I., & Chien, K. R. (1996) · Development · doi:10.1242/dev.122.2.419 · Cited by 183
Bell, R. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(02)00310-3 · Cited by 182
CB2 cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion
Montecucco, F., Lenglet, S., Braunersreuther, V., Burger, F., Pelli, G., Bertolotto, M., Mach, F., & Steffens, S. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.12.014 · Cited by 182
Coronary Microembolization: the Role of TNF- α in Contractile Dysfunction
Dörge, H., Schulz, R., Belosjorow, S., Post, H., van de Sand, A., Konietzka, I., Frede, S., Hartung, T., Vinten-Johansen, J., Youker, K. A., et al. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1489 · Cited by 180
Mocanu, M. M., Bell, R. M., & Yellon, D. M. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2006 · Cited by 178
Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion
Gurevitch, J., Frolkis, I., Yuhas, Y., Paz, Y., Matsa, M., Mohr, R., & Yakirevich, V. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00105-2 · Cited by 170
Monden, Y., Kubota, T., Inoue, T., Tsutsumi, T., Kawano, S., Ide, T., Tsutsui, H., & Sunagawa, K. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00166.2007 · Cited by 170
Tumor Necrosis Factor-α Confers Resistance to Hypoxic Injury in the Adult Mammalian Cardiac Myocyte
Nakano, M., Knowlton, A. A., Dibbs, Z. I., & Mann, D. L. (1998) · Circulation · doi:10.1161/01.cir.97.14.1392 · Cited by 167
Burley, D. S., Ferdinandy, P., & Baxter, G. F. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707409 · Cited by 167
Ligand triggers of classical preconditioning and postconditioning
GROSS, E., & GROSS, G. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.12.019 · Cited by 164
Nakagami, H., Morishita, R., Yamamoto, K., Taniyama, Y., Aoki, M., Matsumoto, K., Nakamura, T., Kaneda, Y., Horiuchi, M., & Ogihara, T. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.581 · Cited by 163
Anti–Tumor Necrosis Factor-Alpha Improves Myocardial Recovery After Ischemia and Reperfusion
Gurevitch, J., Frolkis, I., Yuhas, Y., Lifschitz-Mercer, B., Berger, E., Paz, Y., Matsa, M., Kramer, A., & Mohr, R. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00328-8 · Cited by 160
Skyschally, A., Gres, P., Hoffmann, S., Haude, M., Erbel, R., Schulz, R., & Heusch, G. (2006) · Circulation Research · doi:10.1161/01.res.0000255031.15793.86 · Cited by 160
TNF-?, rheumatoid arthritis, and heart failure: a rheumatological dilemma
Sarzi‐Puttini, P., Atzeni, F., Shoenfeld, Y., & Ferraccioli, G. (2004) · Autoimmunity Reviews · doi:10.1016/j.autrev.2004.09.004 · Cited by 148
Sphingosine Kinase Activation Mediates Ischemic Preconditioning in Murine Heart
Jin, Z.-Q., Goetzl, E. J., & Karliner, J. S. (2004) · Circulation · doi:10.1161/01.cir.0000143632.06471.93 · Cited by 148
Gross, E. R., Hsu, A. K., & Gross, G. J. (2006) · Diabetes · doi:10.2337/db06-0907 · Cited by 138
Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning
Suleman, N., Somers, S., Smith, R., Opie, L. H., & Lecour, S. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn067 · Cited by 133
Self-citationGenetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning
SMITH, R., SULEMAN, N., LACERDA, L., OPIE, L., AKIRA, S., CHIEN, K., & SACK, M. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.06.019 · Cited by 128
Krown, K. A., Yasui, K., Brooker, M. J., Dubin, A. E., Nguyen, C., Harris, G. L., McDonough, P. M., Glembotski, C. C., Palade, P., & Sabbadini, R. A. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01238-5 · Cited by 123
Nishihara, M., Miura, T., Miki, T., Sakamoto, J., Tanno, M., Kobayashi, H., Ikeda, Y., Ohori, K., Takahashi, A., & Shimamoto, K. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00837.2005 · Cited by 122
Smith, R., Suleman, N., McCarthy, J., & Sack, M. N. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00283-3 · Cited by 114
Brar, B. K., Stephanou, A., Liao, Z., O'Leary, R. M., Pennica, D., Yellon, D. M., & Latchman, D. S. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00294-2 · Cited by 111
Frias, M. A., James, R. W., Gerber-Wicht, C., & Lang, U. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp024 · Cited by 110
Peripartum Cardiomyopathy: Recent Insights in its Pathophysiology
Hilfiker‐Kleiner, D., Sliwa, K. S., & Drexler, H. (2008) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2008.05.002 · Cited by 105
Fuglesteg, B. N., Suleman, N., Tiron, C. E., Kanhema, T., Lacerda, L., Andreasen, T. V., Sack, M. N., Jonassen, A. K., Mjøs, O. D., Opie, L. H., et al. (2008) · Basic Research in Cardiology · doi:10.1007/s00395-008-0728-x · Cited by 99
Self-citationSTAT-3 Overexpression and p21 Up-Regulation Accompany Impaired Regeneration of Fatty Livers
Torbenson, M. S., Yang, S. Q., Liu, H. Z., Huang, J., Gage, W. R., & Diehl, A. M. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64167-3 · Cited by 99
Multiple protective pathways against reperfusion injury: A SAFE path without Aktion?
Lecour, S. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.01.003 · Cited by 97
Self-citationIkezoe, T., Saito, T., Bandobashi, K., Yang, Y., Koeffler, H. P., & Taguchi, H. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.473.3.4 · Cited by 96
Mizia‐Stec, K., sior, Z. G., Zahorska‐Markiewicz, B., Janowska, J., Szulc, A., Jastrzebska-Maj, E., & Kobielusz‐Gembala, I. (2003) · Coronary Artery Disease · doi:10.1097/00019501-200309000-00003 · Cited by 95
Connexin 43 in ischemic pre- and postconditioning
Schulz, R., Boengler, K., Totzeck, A., Luo, Y., García‐Dorado, D., & Heusch, G. (2007) · Heart Failure Reviews · doi:10.1007/s10741-007-9032-3 · Cited by 94
Kin, H., Wang, N.-P., Mykytenko, J., Reeves, J. G., Deneve, J., Jiang, R., Zatta, A. J., Guyton, R. A., Vinten‐Johansen, J., & Zhao, A. Z.-Q. (2008) · Shock · doi:10.1097/shk.0b013e31815cfd5a · Cited by 93
Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells
Amit-Vazina, M., Shishodia, S., Harris, D., Van, Q., Wang, M., Weber, D., Alexanian, R., Talpaz, M., Aggarwal, B. B., & Estrov, Z. E. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602637 · Cited by 89
Kuroki, M., & O’Flaherty, J. T. (1999) · Biochemical Journal · doi:10.1042/bj3410691 · Cited by 89
Behrends, M., Schulz, R., Post, H., Alexandrov, A., Belosjorow, S., Michel, M. C., & Heusch, G. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.3.h1111 · Cited by 87
Belosjorow, S., Schulz, R., Dörge, H., Schade, F. U., & Heusch, G. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.277.6.h2470 · Cited by 86
FRIAS, M., Rebsamen, M. C., Gerber-Wicht, C., & Lang, U. E. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.09.016 · Cited by 82
Free radicals trigger TNF?-induced cardioprotection
Lecour, S., Rochette, L., & Opie, L. H. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.10.003 · Cited by 76
Self-citationArany, I., Megyesi, J. K., Nelkin, B. D., & Safirstein, R. L. (2006) · Kidney International · doi:10.1038/sj.ki.5001604 · Cited by 73
The involvement of cytokines in the second window of ischaemic preconditioning
Yamashita, N., Hoshida, S., Otsu, K., Taniguchi, N., Kuzuya, T., & Hori, M. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703594 · Cited by 71
Regulation of Mcl‐1 expression in rheumatoid arthritis synovial macrophages
Liu, H., Huang, Q.-Q., Shi, B., Eksarko, P., Temkin, V., & Pope, R. M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22132 · Cited by 70
Ozog, M. A., Bernier, S. M., Bates, D. C., Chatterjee, B., Lo, C. W., & Naus, C. C. G. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-03-0271 · Cited by 68
Moro, C., Jouan, M.-G., Rakotovao, A., Toufektsian, M.-C., Ormezzano, O., Nagy, N., Tósaki, Á., de Leiris, J., & Boucher, F. R. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00797.2007 · Cited by 64
Nguyen, M. H.-H., Ho, J., Beattie, B. K., & Barber, D. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103100200 · Cited by 63
TNF-α antibodies are as effective as ischemic preconditioning in reducing infarct size in rabbits
Belosjorow, S., Bolle, I., Duschin, A., Heusch, G., & Schulz, R. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00374.2002 · Cited by 60
Flaherty, M. P., Guo, Y., Tiwari, S., Rezazadeh, A., Hunt, G., Sanganalmath, S. K., Tang, X., Bolli, R., & Dawn, B. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.08.014 · Cited by 55
Cardiotrophin-1 is an essential factor in the natural defense of the liver against apoptosis
Marqués, J. M., Belza, I., Holtmann, B., Pennica, D., Prìeto, J., & Bustos, M. (2007) · Hepatology · doi:10.1002/hep.21508 · Cited by 51
Time course and prognostic significance of hemostatic changes in sepsis
Martín, J. C., Peña, J. M. P., Fernandez, A., Jiménez, M. L., Juarez, S., Madero, R., & Vázquez, J. J. (1999) · Critical Care Medicine · doi:10.1097/00003246-199907000-00017 · Cited by 50
TNFα is required to confer protection in an in vivo model of classical ischaemic preconditioning
Deuchar, G. A., Opie, L. H., & Lecour, S. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.01.040 · Cited by 48
Self-citationLedgerwood, E. C., Prins, J. B., Bright, N., Johnson, D. R., Wolfreys, K., Pober, J. S., O’Rahilly, S., & Bradley, J. R. (1998) · PubMed · Cited by 46
Zhang, X., Zhang, J., Wei, H., & Tian, Z. (2007) · Oncology Reports · doi:10.3892/or.17.6.1377 · Cited by 46
Innate immunity and myocardial adaptation to ischemia
Valeur, H. S., & Valen, G. (2008) · Basic Research in Cardiology · doi:10.1007/s00395-008-0756-6 · Cited by 43
Tumour necrosis factor-alpha uncouples respiration in isolated rat mitochondria
Busquets, S., Aranda, X., Ribas‐Carbó, M., Azcón‐Bieto, J., López-Soriano, F. J., & Argilés, J. M. A. (2003) · Cytokine · doi:10.1016/s1043-4666(03)00098-x · Cited by 43
The PGE2-Stat3 interaction in doxorubicin-induced myocardial apoptosis
Frias, M. A., Somers, S., Gerber-Wicht, C., Opie, L. H., Lecour, S., & Lang, U. E. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn171 · Cited by 34
Self-citationRole of tumor necrosis factor alpha and its receptor I in preconditioning by hyperoxia
Labruto, F., Yang, J., Vaage, J., & Valen, G. (2004) · Basic Research in Cardiology · doi:10.1007/s00395-004-0509-0 · Cited by 32
Lacerda, L., Smith, R. M., Opie, L. H., & Lecour, S. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.07.020 · Cited by 31
Self-citationDrug Insight: anti-tumor-necrosis-factor therapy for ankylosing spondylitis
Henderson, C., & Davis, J. C. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0157 · Cited by 26
Giannopoulou, M., Iszkula, S. C., Dai, C., Tan, X., Yang, J., Michalopoulos, G. K., & Liu, Y. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00388.2005 · Cited by 18
Matsumiya, T., Imaizumi, T., Itaya, H., Shibata, T., Yoshida, H., Sakaki, H., Kimura, H., & Satoh, K. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01560-6 · Cited by 16
Fighting the “Fire” of Myocardial Reperfusion Injury
Wu, K. C. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.01.002 · Cited by 15
Durocher, A., Mc, B., Gosset, P., et al. (1991) · PubMed · Cited by 3
Cited by
Heusch, G. (2015) · Circulation Research · doi:10.1161/circresaha.116.305348 · Cited by 811
Cardiovascular remodelling in coronary artery disease and heart failure
Heusch, G., Libby, P., Gersh, B., Yellon, D., Böhm, M., Lopaschuk, G., & Opie, L. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60107-0 · Cited by 734
Ferdinandy, P., Hausenloy, D. J., Heusch, G., Baxter, G. F., & Schulz, R. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008300 · Cited by 562
Ovize, M., Baxter, G. F., Di Lisa, F., Ferdinandy, P., Garcia-Dorado, D., Hausenloy, D. J., Heusch, G., Vinten-Johansen, J., Yellon, D. M., & Schulz, R. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq129 · Cited by 502
TNFα in atherosclerosis, myocardial ischemia/reperfusion and heart failure
Kleinbongard, P., Heusch, G., & Schulz, R. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.05.002 · Cited by 409
Metadata
- Authors
- Lecour, S.
- Venue
- Journal of Molecular and Cellular Cardiology
- Publisher
- Elsevier BV
- Published
- 2009-07
- Volume
- 47
- Issue
- 1
- Pages
- 32-40
- ISSN
- 0022-2828 (ISSN-L)
- OpenAlex
- W2040309436
- Cited by
- 328
- References
- 105
- FWCI
- 15.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.